Shoulder injuries are being treated with a new postage-stamp-sized implant
Mr Andrew Chambler is the first shoulder surgeon in the South West to provide patients with a new innovative shoulder implant. The new biological Regenten™ implant utilises a bovine Achilles tendon to stimulate the body's natural healing response. The treatment encourages the growth of new tendon-like tissue, resulting in shorter rehabilitation and faster recovery for patients.
The ‘rotator cuff’ refers to the small tendons within the shoulder joint. Tendons connect bone to muscle, and a tear in one can cause significant pain and loss of movement in the shoulder joint. A tendon tear can be a result of an injury or accident, or as a result of aging, and the type of tear may affect the treatment suggested.
Mr Chambler, who is leading this treatment at Circle Bath Hospital, spoke in detail about the use of the Regenten™ Bioinductive Implant.
“The implant, which is about the size of a postage stamp, is inserted through a small incision during a minimally invasive procedure. It is held in place with anchors until new tissue grows into the implant and remodels into tendon-like tissue. Gradually over the course of 6 months, this is absorbed, leaving a layer of new tissue to biologically augment the existing tendon.
“Traditional approaches to treating rotator cuff injuries focus only on biomechanical repair, but do not address the underlying biology of the tendon,” said Mr Chambler.
This can result in tears progressing or re-tears in the rotator cuff tendon after an initial repair. Many patients avoid surgery to repair the tear because they hear about painful, lengthy postoperative rehabilitation and time away from work.
Depending on your stage of rotator cuff disease, REGENETEN™ can provide a range of potential benefits, including shorter rehabilitation, faster recovery, prevention or slowing of disease progression, healing of partial-thickness tears, and decreased risk of developing a subsequent degenerative tear.”
A study conducted in Sydney, Australia, highlighted there were no observations of adverse reactions to the implant, and all patients showed consistent improvement in clinical scores.
MRI results showed that a layer of new tendinous tissue was induced in all of the patients, with a 64 percent increase in tendon thickness within the first 12 months.
In addition, partial-thickness defects were filled in without any evidence of tear progression, and there were no re-tears in the full-thickness repair patients.
“This implant treats a common problem in a way that has never been done before, and I’m delighted to be working alongside the team at Circle Bath Hospital to bring this innovative treatment to our patients.
Together with Circle Bath, I have already undertaken this technique on a number of patients within my care”.
We continue to support the local NHS resilience initiatives and our private care pathways amid the pandemic. We have implemented a number of robust changes to ensure the safety of our patients and staff.